Bicycle therapeutics announces restrictions on shareholder attendance at annual general meeting to be held on june 28, 2021

Cambridge, england, & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced an update regarding shareholder attendance at its 2021 annual general meeting (the “agm”) to be held on june 28, 2021. as noted in bicycle's notice of 2021 annual general meeting (the “meeting notice”) and the accompanying proxy statement (the “pro
BCYC Ratings Summary
BCYC Quant Ranking